| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |